Overview

A Study of Gemcitabine ± Erlotinib and DN-101 Versus Gemcitabine ± Erlotinib and Placebo in Patients With Advanced Pancreatic Cancer

Status:
Suspended

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the safety and efficacy of an investigational study drug DN-101 (calcitriol) when given in combination with gemcitabine ± erlotinib in the treatment of pancreatic cancer.

Phase:

Phase 2

Details

Lead Sponsor:

Novacea

Collaborator:

Schering-Plough

Treatments:

Calcitriol
Erlotinib Hydrochloride
Gemcitabine